African swine fever control and prevention: an update on vaccine development
- PMID: 35912875
- PMCID: PMC9423837
- DOI: 10.1080/22221751.2022.2108342
African swine fever control and prevention: an update on vaccine development
Abstract
African swine fever (ASF) is a lethal and highly contagious viral disease of domestic and wild pigs, listed as a notifiable disease reported to the World Organization for Animal Health (OIE). Despite its limited host range and absent zoonotic potential, the socio-economic and environmental impact of ASF is very high, representing a serious threat to the global swine industry and the many stakeholders involved. Currently, only control and eradication measures based mainly on early detection and strict stamping-out policies are available, however, the rapid spread of the disease in new countries, and in new regions in countries already affected, show these strategies to be lacking. In this review, we discuss approaches to ASF vaccinology, with emphasis on the advances made over the last decade, including the development of virulence-associated gene deleted strains such as the very promising ASFV-G-ΔI177L/ΔLVR, that replicates efficiently in a stable porcine epithelial cell line, and the cross-protecting BA71ΔCD2 capable of stably growing in the commercial COS-1 cell line, or the naturally attenuated Lv17/WB/Rie1 which shows solid protection in wild boar. We also consider the key constraints involved in the scale-up and commercialization of promising live attenuated and virus-vectored vaccine candidates, namely cross-protection, safety, lack of suitable animal models, compatibility with wildlife immunization, availability of established and licensed cell lines, and differentiating infected from vaccinated animals (DIVA) strategy.
Keywords: African swine fever; control; domestic pigs; immune response; live attenuated; review; vaccine; wild boar.
Conflict of interest statement
No potential conflict of interest was reported by the author(s).
Figures



References
-
- Rowlands RJ, Michaud V, Heath L, et al. . African swine fever virus isolate, Georgia, 2007. Emerg Infect Dis [Internet]. 2008;14:1870–1874. Available from: https://pubmed.ncbi.nlm.nih.gov/19046509. - PMC - PubMed
-
- Kolbasov D, Titov I, Tsybanov S, et al. . African Swine Fever Virus, Siberia, Russia, 2017. Emerg Infect Dis [Internet]. 2018;24:796–798. Available from: https://pubmed.ncbi.nlm.nih.gov/29553323. - PMC - PubMed
-
- World Organisation for Animal Health. African Swine Fever Global Situation [Internet] . OIE WAHIS. 2022 [cited 2022 Apr 10]. Available from: https://www.oie.int/en/disease/african-swine-fever/#ui-id-2.
-
- Andrés G, Charro D, Matamoros T, et al. . The cryo-EM structure of African swine fever virus unravels a unique architecture comprising two icosahedral protein capsids and two lipoprotein membranes. J Biol Chem. [Internet]. 2020;295:1, [cited 2022 Jun 29]; Available from: /pmc/articles/PMC6952596/. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources